Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Pathology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2353/ajpath.2009.080671PMID 19095947PMCID PMC2631324
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Arachidonic Acid Metabolites and the Kidney

  2011cited by this paper
• Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats.

  2007cited by this paper
• Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells.

  2006cited by this paper
• Apoptotic Cells, through Transforming Growth Factor-β, Coordinately Induce Anti-inflammatory and Suppress Pro-inflammatory Eicosanoid and NO Synthesis in Murine Macrophages*

  2006cited by this paper
• Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.

  2005cited by this paper
• Diminished lipoxin biosynthesis in severe asthma.

  2005cited by this paper
• Modulation of interferon-induced genes by lipoxin analogue in anti-glomerular basement membrane nephritis.

  2004cited by this paper
• Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease.

  2004cited by this paper
• Monocyte chemoattractant protein-1 and interleukin-8 levels in children with acute poststreptococcal glomerulonephritis

  2004cited by this paper
• Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo.

  2002cited by this paper
• Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4

  2002cited by this paper
• Urinary Excretion of Lipoxin A4 and Related Compounds: Development of New Extraction Techniques for Lipoxins

  2002cited by this paper
• Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes

  2002cited by this paper
• 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure.

  2002cited by this paper
• Diseases of the Kidney and Urinary Tract

  2001cited by this paper
• Cutting Edge: Lipoxin (LX) A4 and Aspirin-Triggered 15-Epi-LXA4 Block Allergen-Induced Eosinophil Trafficking1

  2000cited by this paper
• Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis

  1999cited by this paper
• Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis.

  1999cited by this paper
• Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis.

  1997cited by this paper
• Regulation of 15-lipoxygenase expression in lung epithelial cells by interleukin-4.

  1996cited by this paper
• Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase.

  1992cited by this paper
• Fifteen-S-hydroxyeicosatetraenoic acid (15-S-HETE) specifically antagonizes the chemotactic action and glomerular synthesis of leukotriene B4 in the rat.

  1992cited by this paper
• Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids.

  1990cited by this paper
• Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine.

  1989cited by this paper
• Transformation of leukotriene A4 to lipoxins by rat kidney mesangial cell.

  1989cited by this paper

• Specialized pro-resolving mediators in neutrophil apoptosis regulation: unlocking novel therapeutic potential in kidney diseases

  2025cites this paper
• Polyunsaturated fatty acids in kidney diseases: Navigating the fine line between healing and damage.

  2025cites this paper
• Angiotensin II and post-streptococcal glomerulonephritis

  2024cites this paper
• Mechanisms of 15-Epi-LXA4-Mediated HO-1 in Cytoprotection Following Inflammatory Injury.

  2022cites this paper
• Lipoxins and synthetic lipoxin mimetics: therapeutic potential in renal diseases.

  2021cites this paper
• Acute post-streptococcal glomerulonephritis: analysis of the pathogenesis

  2020cites this paper
• Sex‐mediated elevation of the specialized pro‐resolving lipid mediator levels in a Sjögren's syndrome mouse model

  2020cites this paper
• Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease.

  2020cites this paper
• The Lipoxin A4 Receptor Agonist BML-111 Alleviates Inflammatory Injury and Oxidative Stress in Spinal Cord Injury

  2020cites this paper
• The Association between Serum Lipoxin A4 Level and Lupus Nephritis

  2019cites this paper
• Lipoxin A4 Regulates Lipopolysaccharide-Induced BV2 Microglial Activation and Differentiation via the Notch Signaling Pathway

  2019cites this paper
• Arachidonic Acid Metabolism and Kidney Inflammation

  2019cites this paper
• Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome

  2018cites this paper
• Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications

  2018cites this paper
• The atheroprotective role of lipoxin A4 prevents oxLDL-induced apoptotic signaling in macrophages via JNK pathway.

  2018cites this paper
• Effects of Lipoxin A 4 Receptor Agonist and Interleukin鄄 1 茁 in Toll鄄Like Receptors / Mycloid Differentiation Factor 88 / Nuclear Factor鄄资B Signal Pathway on Asthma Mice with Airway Inflammation

  2018cites this paper
• Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes.

  2017cites this paper
• A rare adult case of poststreptococcal acute glomerulonephritis with a retropharyngeal abscess

  2017cites this paper
• Specialized pro-resolving mediators in renal fibrosis.

  2017cites this paper
• Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.

  2017cites this paper
• Re-Examining Neutrophil Participation in GN.

  2017cites this paper
• Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

  2017cites this paper
• Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids

  2016cites this paper
• Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast

  2016cites this paper
• The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.

  2015cites this paper
• Roles of lipoxin A4 receptor activation and anti-interleukin-1β antibody on the toll-like receptor 2/mycloid differentiation factor 88/nuclear factor-κB pathway in airway inflammation induced by ovalbumin

  2015influential citation
• Health effects of changes in the structure of dietary macronutrients intake in western societies.

  2015cites this paper
• Lipid mediators in the resolution of inflammation.

  2015cites this paper
• [Acute glomerulonephritis in the 21-st century].

  2015cites this paper
• Urinary lipoxin A4 as a biomarker for systemic lupus erythematosus

  2015cites this paper
• Analyse des Nephropathiespektrums am Universitätsklinikum Leipzig von 1983 bis 2010

  2015cites this paper
• Immune-Mediated Glomerular Injury in Children

  2015cites this paper
• Lipoxin A4 Inhibits NF-κB Activation and Cell Cycle Progression in RAW264.7 Cells

  2014cites this paper
• Resolution of inflammation: targeting GPCRs that interact with lipids and peptides

  2014cites this paper
• [Resolving factors of inflammation - a bridge between innate immunity and adaptive immunity].

  2013cites this paper
• Obesity, immunomodulation and chronic kidney disease.

  2013cites this paper
• Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II

  2013cites this paper
• Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II

  2013cites this paper
• Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci: Receptor-Dependent Actions

  2012cites this paper
• Infection-related glomerulonephritis: changing demographics and outcomes.

  2012cites this paper
• Transcriptional Regulation of 15-Lipoxygenase Expression by Histone H3 Lysine 4 Methylation/Demethylation

  2012cites this paper
• Is multiple sclerosis a proresolution deficiency disorder?

  2012cites this paper
• Limits Polymorphonuclear Leukocytes Recruitment to Inflammatory Loci Receptor-Dependent Actions

  2012cites this paper
• Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators.

  2012cites this paper
• Chemical Mediators of Inflammation and Resolution in Post-Operative Abdominal Aortic Aneurysm Patients

  2012cites this paper
• Lipoxins as biomarkers of lupus and other inflammatory conditions

  2011cites this paper
• Resolvins and protectins in inflammation resolution.

  2011cites this paper
• 17(R)‐Resolvin D1 differentially regulates TLR4‐mediated responses of primary human macrophages to purified LPS and live E. coli

  2011cites this paper
• 2-Polyunsaturated Acyl Lysophosphatidylethanolamine Attenuates Inflammatory Response in Zymosan A-Induced Peritonitis in Mice

  2011cites this paper
• Endogenous Anti-inflammatory and Proresolving Lipid Mediators in Renal Disease

  2011cites this paper
• The effect of n-3 polyunsaturated fatty acids on leukotriene B₄ and leukotriene B₅ production from stimulated neutrophil granulocytes in patients with chronic kidney disease.

  2011cites this paper
• Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.

  2011cites this paper
• Possible strategies for anti-fibrotic drug intervention in scleroderma

  2011cites this paper
• Role of the lipoxin A4 receptor in inflammation

  2010cites this paper
• Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation

  2010cites this paper
• A Novel Genus of Specialized Anti-Inflammatory and Pro-Resolution Lipid Mediators

  2010cites this paper
• Molecular Circuits of Resolution in Renal Disease

  2010cites this paper
• Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?

  2010cites this paper
• Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree

  2010cites this paper
• Montelukast, A Selective Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces Cerulein-Induced Pancreatic Injury in Rats

  2010cites this paper
• Lipoxins: regulators of resolution.

  2010cites this paper
• Lipoxins: resolutionary road

  2009cites this paper
• THEMED SECTION: MEDIATORS AND RECEPTORS IN THE RESOLUTION OF INFLAMMATION REVIEW Lipoxins: resolutionary road

  2009cites this paper